Even so , the idea is not without merit despite the questionable motives of its outside influencers . The merger and subsequent split ? should regulators allow it , and US regulators have grown a pair over the last 18 months or so ? is nothing short of an outright victory for a handful of the biggest names in hedge funds and activist investment . Nelson Peltz of Trian Partners lost the battle against Ms Kullman at Du Pont but appears to have won the war . Meanwhile , Daniel Loeb of Third Point has been just as aggressive with the board of Dow Chemical . To the victors , the spoils : both stand to reap significant profits if the deal goes ahead as planned .
